"Future of Executive Summary Immuno-Oncology (IO) Market: Size and Share Dynamics
CAGR Value
Data Bridge Market Research analyses that the immuno-oncology (IO) market, which is USD 28.10 billion in 2022, is expected to reach USD 156.05 billion by 2030, at a CAGR of 23.9% during the forecast period 2023 to 2030.
To thrive in this rapidly transforming marketplace, today’s businesses call...
The biotechnology sector is playing a crucial role in advancing CAR-T cell therapy technologies. Innovative companies are focusing on improving manufacturing processes and treatment efficiency. These developments are strengthening the competitive landscape of the market.
CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR
The global CAR-T Cell Therapy Market is...
The field of oncology is undergoing a historic paradigm shift, moving away from broad-spectrum chemotherapies and towards hyper-targeted, personalized immunotherapies. At the vanguard of this movement is Chimeric Antigen Receptor T-cell (CAR-T) therapy, a process that engineers a patient's own immune system to hunt and destroy cancer. However, creating these "living drugs" requires a highly...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt